Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins.

In line with our definition of PSTF, all patients experienced highly significant deterioration ( p < 0.001) of CD severity during the last 6 months before onset of incoBoNT/A therapy ( Figure 1 ).

also in 132,142 other papers

Improvements were also observed at week 48 for the TWSTRS subscale pain, and for total TWSTRS; however, they failed to reach significance ( Table 1 ).

also in 4,113 other papers